24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biomed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:51
Intel’s Israeli workforce hits decade low as more layoffs loom
10:55
As Israeli tech ecosystem matures, the meaning of exit evolves
10:28
"It’s important to plan the vision from the very beginning"
10:20
“Selling the product is the easy part. Convincing people to believe in you is the hard part”
More stories
Buzz
Most popular
Daily
Weekly
1
Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option
2
Lightrun raises $70 million to bring AI-powered real-time remediation to enterprise software
3
Palo Alto Networks to buy Protect AI for estimated hundreds of millions amid AI security race
4
Adam Neumann’s Flow raises over $100M at $2.5B valuation
5
Upwind acquires Nyx Security to strengthen real-time cloud application protection
More news
Biomed
9 stories about Biomed
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Gives Nasdaq IPO Another Shot
21.05.18
|
Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange
29.04.18
|
Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
An Israeli Company Wants to Treat Tourette Syndrome With Cannabis
09.04.18
|
Lilach Baumer
Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday
For the Fourth Time, Entera Bio Tries for Nasdaq IPO
08.01.18
|
Dror Reich
The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter
Biomed Company Protalix to Lay Off a Fifth of its Workforce
26.11.17
|
Dror Reich
The Israel-based NYSE American-listed company is currently undergoing a streamlining process
Entera Bio Files for Nasdaq IPO
12.11.17
|
Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
Collplant Takes a Step Towards 3D Organ Printing
17.10.17
|
Lilach Baumer
The Israel-based company develops collagen-based biological ink for 3D organ printing
IPO Hopeful Entera Bio Moves to Better Position
13.09.17
|
Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
Previous Articles